sulfinpyrazone has been researched along with dipyridamole in 275 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 258 (93.82) | 18.7374 |
| 1990's | 12 (4.36) | 18.2507 |
| 2000's | 1 (0.36) | 29.6817 |
| 2010's | 4 (1.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Jobin, F | 2 |
| Glusa, E | 1 |
| Haft, JI | 1 |
| Bream, ML; Ferguson, GG; Philp, RB | 1 |
| Loo, J | 1 |
| Dechavanne, M; Lagarde, M | 1 |
| Hanson, SR; Harker, LA | 2 |
| Allain, P; Leblondel, G | 1 |
| Rosenberg, JC; Sell, TL | 1 |
| Rosenberg, JC; Sell, T | 1 |
| Ferber, RH; Parrish, SL; Vigdahl, RL | 1 |
| Bandinelli, C; Bellini, PG; De Mauro, G; Provvedi, D; Rubegni, M | 1 |
| Deykin, D; Gurewich, V; Harker, L; Hirsch, J | 1 |
| Genton, E; Rainwater, J; Steele, P; Vogel, R | 1 |
| Mustard, JF; Packham, MA | 1 |
| Loeliger, EA | 1 |
| Didisheim, P; Fuster, V | 2 |
| Verstraete, M | 6 |
| Hirsh, J; Turpie, AG | 1 |
| Kinlough-Rathbone, RL; Mustard, JF; Packham, MA | 3 |
| Furlan, AJ; Sandok, BA; Sundt, TM; Whisnant, JP | 1 |
| Yasunaga, K | 2 |
| Byrnes, JJ; Lian, EC | 1 |
| Hirsh, J | 5 |
| Dettori, AG; Pini, M; Quintavalla, R | 1 |
| Latour, JG | 1 |
| Dmoszyńska-Giannopoulou, A; Pluta, A | 1 |
| Mitchell, JR | 2 |
| Novo, S; Strano, A | 1 |
| Ostendorf, P | 1 |
| Gantmacher, ML | 1 |
| Schott, G | 1 |
| al-Mefty, O; Marano, G; Nugent, GR; Raiaraman, S; Rodman, N | 1 |
| Oelz, O | 1 |
| Mehta, J; Mehta, P | 1 |
| Mantovani, M; Niada, R; Pescador, R | 1 |
| Hladovec, J | 4 |
| Zabel Langhennig, R | 1 |
| Kanzaki, M; Yasunaga, K | 1 |
| Adams, JH; Mitchell, JR | 1 |
| Baumgartner, HR | 1 |
| Dechavanne, M; Follea, G; Trzeciak, MC | 1 |
| Amorosi, EL; Karpatkin, S | 1 |
| Bozdech, MJ; Crowell, EB; Eckel, RH; Waterhouse, BE | 1 |
| Beck, R; Cornell, CJ; Smith, RE; Stern, R | 1 |
| Burns, TS; Saunders, RN; Stelzer, MR; Waskawic, ER | 1 |
| Buchanan, M; Hirsh, J | 2 |
| Weiss, HJ | 3 |
| Loew, D | 1 |
| Deykin, D | 1 |
| Gent, M; Genton, E; Harker, LA; Hirsh, J | 4 |
| Doub, NH; Doub, PH; Klimt, CR | 1 |
| Gallus, AS; Hirsh, J | 1 |
| Köhler, H | 1 |
| Langley, PG; Rubin, MH; Westaby, S; Weston, MJ; Williams, R | 1 |
| Corn, M | 1 |
| Gotshall, RA; Harker, LA | 1 |
| Kinlough-Rathbone, RL; Moore, S; Mustard, JF; Packham, MA | 1 |
| Weber, E | 1 |
| Dalessio, DJ | 1 |
| Arfors, KE; Bergqvist, D; Tangen, O | 1 |
| Gent, M; Genton, E; Hirsh, J | 1 |
| Davies, H; Genton, E; Ppppas, G; Steele, P; Weily, H | 1 |
| Kendall, MJ | 1 |
| Thiele, KG | 1 |
| Ellis, J; Genton, E; Steele, P | 1 |
| de Gaetano, G | 1 |
| Vermylen, J | 1 |
| Hattori, A | 1 |
| Easton, JD | 1 |
| Ferlito, S | 1 |
| Jafri, SM | 1 |
| Delahaye, JP; Sagnol, P | 1 |
| Battista, RN; Boucher, J; Bravo, G; Côté, R; Stachenko, SJ | 1 |
| Anzalone, N; Baldereschi, M; Bonatti, ML; Candelise, L; Fratiglioni, L; Gandolfo, C; Inzitari, D; Mamoli, A; Prencipe, M; Rasura, M | 1 |
| Mathur, AK; Mittal, SR; Tandon, R | 1 |
| Buring, JE; Hennekens, CH | 1 |
| Copeland, JG; Goldman, S; Henderson, WG; Moritz, T; Sethi, GK; Zadina, K | 1 |
| Kienast, J; Verstraete, M | 1 |
| del Zoppo, GJ | 1 |
| Fuster, V; Stein, B | 1 |
| Chesler, E; Copeland, J; Doherty, J; Goldman, S; Henderson, W; Moritz, T; Ovitt, T; Read, R; Sako, Y; Zadina, K | 1 |
| Shalaev, SV | 1 |
| Bélanger, GL; Lavallée, JP; Lenis, J; Ouellet, CA | 1 |
| Borhani, NO | 1 |
| Tomov, I | 1 |
| Gelman, JS; Mehta, J | 1 |
| Frishman, WH; Miller, KP | 1 |
| Bollinger, A | 1 |
| Huxtable, RJ; Keith, IM; Weir, K; Will, JA | 1 |
| Matsuda, T | 1 |
| Harker, LA | 2 |
| Cattran, DC; Chow, S; Roscoe, J | 1 |
| Goldman, M; McCollum, CN | 1 |
| Chesebro, JH; Fuster, V; Steele, PM | 1 |
| Liusov, VA; Savenkov, MP | 1 |
| Botindari, G; Catalano, I; Davì, G; Strano, A | 1 |
| Chalmers, TC; Pincus, MM; Reitman, D; Sacks, HS; Sze, PC | 1 |
| Cairns, JA | 1 |
| Bjornsson, TD; Hanson, SR; Harker, LA | 2 |
| Limet, R | 1 |
| Fuster, V; Hirsh, J; Salzman, E | 1 |
| Chediak, J; Hirsh, J; Lewis, D; Resnekov, L | 1 |
| Brown, BG; Chesebro, JH; Ekeström, S; Harker, LA; Henderson, AH; Jewitt, DE; Oliver, MF; Sleight, P; Verstraete, M | 1 |
| Głab-Kordecka, E | 1 |
| Böhm, R | 1 |
| Fujimoto, T; Yamazaki, H | 1 |
| Lecompte, T; Samama, M | 1 |
| David, JL | 1 |
| Lemberg, L; Valladares, BK | 1 |
| Di Perri, T | 1 |
| Gallus, AS | 1 |
| Chiu, HM; Dotten, DA; Poldre, P; Pruzanski, W | 1 |
| Sherry, S | 3 |
| Rühle, H | 1 |
| FitzGerald, GA; Pedersen, AK | 1 |
| Davies, JA | 1 |
| Jouve, R; Larrue, J | 1 |
| Hashimoto, N; Kholoussy, AM; Kumashiro, R; Matsumoto, T; Piotrowski, JJ | 1 |
| Capel, P | 1 |
| Grunwald, J; Haudenschild, CC | 1 |
| Rosenstein, R | 1 |
| Friemel, G; Kurz, H | 1 |
| Douglas, AS | 1 |
| Lekas, N; Lysz, K; Morrell, R; Rosenberg, JC; Sell, T; Villalalva, A | 1 |
| Arieff, AI; Pinggera, WF | 1 |
| Bove, LG | 1 |
| Didisheim, P; Fuster, V; Kazmier, FJ | 1 |
| Forbes, CD; Prentice, CR | 1 |
| Millikan, CH | 1 |
| Muirhead, CR | 1 |
| Deuticke, B | 1 |
| Peterson, J; Zucker, MB | 1 |
| Perlick, E | 1 |
| McNicol, GP | 1 |
| Genton, E | 1 |
| Schröder, R | 1 |
| Marshall, AJ | 1 |
| de Bono, DP | 1 |
| Breddin, K; Loew, D; Uberla, K | 1 |
| Gross, F | 1 |
| Bertelè, V; Cerletti, C; de Gaetano, G | 1 |
| Adachi, K; Toshima, H | 1 |
| Spann, JF | 1 |
| Kelton, JG | 1 |
| Offerhaus, L | 1 |
| Dalen, JE; Goldberg, RJ; Gore, JM; Struckus, J | 1 |
| Hirsh, J; Kelton, JG | 1 |
| Bolte, HD | 1 |
| Bukowski, RM; Groppe, CW; Hewlett, JS; Livingston, RB; Reimer, RR; Weick, JK | 1 |
| Hinton, RC | 1 |
| Tullio, D | 1 |
| Bettmann, MA; Garnic, JD; Murray, PD | 1 |
| Buckler, P; Douglas, AS | 1 |
| Webster, J | 1 |
| Thiele, R | 1 |
| FitzGerald, GA; Sherry, S | 1 |
| Butt, R; de Boer, AC; Gent, M; Genton, E; Han, P; Turpie, AG | 1 |
| Guiraud-Chaumeil, B | 1 |
| Faxon, DP; Haudenschild, CC; Ryan, TJ; Sanborn, TA | 1 |
| Carter, WJ; Liem, PH; Wilkerson, RJ | 1 |
| Kester, RC | 1 |
| Birgens, HS; Hansen, MS | 2 |
| Avellone, G; Davì, G; Mandalà, V; Novo, S; Pinto, A; Raneli, G; Riolo, FP | 1 |
| Gaillard, JL; Kher, A; Lecompte, T; Samama, M | 1 |
| Bousser, MG | 2 |
| Mehta, J | 1 |
| Stamler, J | 1 |
| Bertha, G; Lechner, H; Ott, E | 1 |
| Ramirez-Lassepas, M | 1 |
| Eichner, ER | 1 |
| Barnett, HJ | 1 |
| Ordinas, A | 1 |
| Dworski, R; Musiał, J; Szczeklik, A | 1 |
| Gitler, B; Gitler, ES | 1 |
| Block, LH; Rhyner, K; Stenger, M | 1 |
| Lewis, GP; Smith, JR | 1 |
| Kaliman, J; Sinzinger, H; Strobl-Jäger, E | 1 |
| Crow, MJ; Kester, RC; McCollum, CN; Rajah, SM | 1 |
| Butler, KD; White, AM | 1 |
| Bouchier-Hayes, D | 1 |
| Nair, CK; Pagano, T; Sketch, MH | 1 |
| Mannucci, PM | 1 |
| Giannini, SD; Guerra, JL; Merusse, JL; Sanchis, FS | 1 |
| Ritchie, JL; Stratton, JR | 1 |
| Van Aken, WG | 1 |
| Verdecchia, P | 2 |
| Barajas, L; Chen, AF; Morin, RJ; Moss, RA; Narayanan, AS; Raye, C; Srikantaiah, MV | 1 |
| Cortellaro, M; Polli, EE | 1 |
| Chelapurath, A; Essers, U; Häussinger, G; Pfennigs, H; Reul, H | 1 |
| Burg, J; Gaudiani, VA; Jamieson, SW; Kosek, JC; Miller, DC | 1 |
| Kazmier, FJ | 1 |
| Deck, JH; Kelton, JG; Littlejohn, GO; Reynolds, WJ | 1 |
| Brass, LF; Shattil, SJ | 1 |
| Held, K | 1 |
| Männistö, J; Uotila, P | 1 |
| Poliwoda, H | 1 |
| Jones, RJ | 1 |
| Bunting, S; Moncada, S; O'Grady, J | 1 |
| Chesebro, JH; Fuster, V | 3 |
| Billingham, ME; Harrison, DC; Jamieson, SW; Lurie, KG; Reitz, BA | 1 |
| Kanazawa, T; Matsuoka, H | 1 |
| Sternon, J | 1 |
| Loogen, F; Misera, R; Reimers, HJ; Schneider, W | 1 |
| Sloan, RW | 1 |
| Cristol, R | 1 |
| Turpie, AG | 2 |
| Prentice, CR | 1 |
| Castaldi, PA | 1 |
| Boissel, JP; Destors, JM; Gillet, J; Leizorovicz, A; Schbath, J | 1 |
| Mehta, JL | 1 |
| Schöndorf, TH | 1 |
| Meloche, JP | 1 |
| Boeynaems, JM | 1 |
| Marquardsen, J; Sørensen, PS | 1 |
| Clark, WF; Moriarity, TA; Reid, BD; Tevaarwerk, GJ | 1 |
| Deuel, T; Gardner, F; Peck, WA | 1 |
| Cornu, P; Gratwohl, A; Richner, J; Speck, B | 1 |
| Bozdech, MJ; Johnson, CA; Updike, SJ; Zimmerman, SW | 1 |
| Frankel, AE; Rubenstein, MD; Wall, RT | 1 |
| Aubert, D; Ferrand, C; Loubrie, JC; Tuong, A; Tuong, CC | 1 |
| Hamilton, GW; Harker, LA; Huang, TW; Ritchie, JL; Stratton, JR; Thiele, B; Warrick, LN | 1 |
| Lorenz, R; Siess, W; Weber, PC | 1 |
| Donner, L | 1 |
| Ahmad, S | 1 |
| Rainwater, J; Steele, P | 1 |
| Kahn, SB | 1 |
| Culliton, BJ; Waterfall, WK | 1 |
| Paredero Del Bosque Martin, V | 1 |
| Croveri, G | 1 |
| Copeland, J; Goldman, S; Henderson, WG; Moritz, T; Sethi, G | 1 |
| Dalen, JE; Goldman, S; Stein, PD; Théroux, P | 1 |
| Buyniski, JP; Fleming, JS | 1 |
92 review(s) available for sulfinpyrazone and dipyridamole
| Article | Year |
|---|---|
[Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Analgesics; Anti-Inflammatory Agents; Arteriosclerosis; Aspirin; Blood Coagulation; Blood Platelets; Cardiovascular Diseases; Dipyridamole; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; In Vitro Techniques; Indomethacin; Oxyphenbutazone; Phenylbutazone; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Time Factors | 1976 |
[Inhibition of blood platelet function].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antimalarials; Aspirin; Chloroquine; Dipyridamole; Female; Humans; Maternal-Fetal Exchange; Platelet Aggregation; Pregnancy; Sulfinpyrazone; Vasodilator Agents | 1979 |
Role of blood platelets in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Evaluation; Humans; Myocardial Infarction; Placebos; Platelet Aggregation; Prostaglandins, Synthetic; Spasm; Sulfinpyrazone | 1979 |
Clinical pharmacology of platelets.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation; Blood Platelets; Cell Membrane; Clofibrate; Cyproheptadine; Dipyridamole; Drug Therapy, Combination; Furosemide; Halofenate; Heparin; Humans; Hydrocortisone; Hydroxychloroquine; Methylprednisolone; Penicillin G; Platelet Aggregation; Propranolol; Prostaglandins; Sulfinpyrazone; Vitamin E | 1977 |
[Prevention of thrombosis with coumarin, low doses of heparin, dextran and inhibitors of platelet function].
Topics: Aspirin; Coumarins; Dextrans; Dipyridamole; Heart Valve Prosthesis; Heparin; Humans; Lipids; Platelet Aggregation; Postoperative Care; Preoperative Care; Sulfinpyrazone; Thrombosis; Xanthinol Niacinate | 1977 |
Actions and clinical status of platelet-suppressive agents.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Sulfinpyrazone; Thrombosis | 1978 |
Platelet function inhibitors: their clinical use.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Platelet Aggregation; Renal Dialysis; Sulfinpyrazone; Thromboembolism | 1978 |
[Indications and uncertainties of antiaggregating agents].
Topics: Anticoagulants; Aspirin; Clofibrate; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1977 |
Platelet suppressive therapy.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1978 |
Platelets and thrombosis in the development of atherosclerosis and its complications.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Dipyridamole; Endothelium; Humans; Hyperlipidemias; Lipids; Rabbits; Sulfinpyrazone; Thrombosis | 1978 |
[Clinical application and evaluation of anti-platelet agents].
Topics: Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Female; Humans; Intracranial Embolism and Thrombosis; Male; Myocardial Infarction; Prostheses and Implants; Sulfinpyrazone; Thrombophlebitis | 1978 |
Recent therapeutic advances in thrombotic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aspirin; Blood Transfusion; Dextrans; Dipyridamole; Exchange Transfusion, Whole Blood; Female; Glucocorticoids; Humans; Male; Plasma; Plasmapheresis; Platelet Aggregation; Purpura, Thrombotic Thrombocytopenic; Splenectomy; Sulfinpyrazone | 1979 |
Antiplatelet drugs in thromboembolism.
Topics: Anticoagulants; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1979 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thromboembolism; Thrombosis | 1978 |
[Treatment with antiplatelet drugs. Current status of knowledge].
Topics: Aspirin; Blood Platelet Disorders; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dextrans; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Platelet Aggregation; Postoperative Complications; Sulfinpyrazone; Thromboembolism | 1979 |
[Clinical prevention of thrombosis by antiplatelet agents].
Topics: Aspirin; Blood Platelets; Clofibrate; Dipyridamole; Humans; Hydroxychloroquine; Sulfinpyrazone; Thrombosis | 1979 |
[State of thrombosis risk: diagnostic and preventive possibilities].
Topics: Anticoagulants; Aspirin; Dipyridamole; Humans; Platelet Aggregation; Risk; Sulfinpyrazone; Thrombosis | 1979 |
[Prophylactic value of platelet anti-aggregants in coronary disease].
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Embolism; Heart Valve Prosthesis; Humans; Myocardial Infarction; Platelet Aggregation; Postoperative Complications; Sulfinpyrazone | 1979 |
[Prospects of antiaggregant therapy in prevention of atherosclerosis].
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Dipyridamole; Epoprostenol; Humans; Hyperlipidemias; Indomethacin; Papaverine; Platelet Aggregation; Prostaglandins; Prostaglandins, Synthetic; Sulfinpyrazone; Xanthines | 1979 |
Antiplatelet agents: a review.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Female; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Male; Myocardial Infarction; Postoperative Complications; Sulfinpyrazone; Thromboembolism | 1979 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Kidney Diseases; Kidneys, Artificial; Male; Silicone Elastomers; Sulfinpyrazone; Thromboembolism; Thrombosis; Vascular Diseases | 1975 |
Clinical trials in thrombosis: secondary prevention of myocardial infarction.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Myocardial Infarction; Prospective Studies; Sulfinpyrazone; Thromboembolism | 1976 |
Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Brain; Clofibrate; Dextrans; Dipyridamole; Humans; Ischemia; Kidney Diseases; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Serotonin Antagonists; Sulfinpyrazone; Sympathomimetics; Thrombosis | 1976 |
Antithrombotic drugs: part II.
Topics: Anabolic Agents; Ancrod; Animals; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyridamole; Fibrinolytic Agents; Humans; Hydroxychloroquine; Myocardial Infarction; Plasminogen Activators; Streptokinase; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Urokinase-Type Plasminogen Activator | 1976 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Prospective Studies; Pyrimidines; Retrospective Studies; Sulfinpyrazone; Thromboembolism; Warfarin | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Graft Rejection; Humans; Kidney Transplantation; Male; Myocardial Infarction; Sulfinpyrazone; Thromboembolism; Thrombosis; Transplantation, Homologous | 1975 |
Antiplatelet therapy in the prevention of stroke.
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sulfinpyrazone; Ticlopidine | 1991 |
[Platelet antiaggregants in the treatment of arterial thrombosis].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Cerebrovascular Disorders; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Follow-Up Studies; Heart Valve Prosthesis; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sulfinpyrazone; Thrombosis | 1991 |
Antiplatelet and anticoagulant therapy in acute myocardial infarction.
Topics: Aspirin; Dipyridamole; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Sulfinpyrazone; Warfarin | 1991 |
[Anticoagulant or antiplatelet aggregation treatment after aortocoronary bypass].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Sulfinpyrazone; Ticlopidine; Vitamin K | 1991 |
Aspirin in transient ischemic attacks and minor stroke: a meta-analysis.
Topics: Adult; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Meta-Analysis as Topic; Middle Aged; Randomized Controlled Trials as Topic; Sulfinpyrazone | 1991 |
[Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"].
Topics: Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Middle Aged; Prognosis; Sulfinpyrazone | 1990 |
Pharmacology of the interaction between platelets and vessel wall.
Topics: Animals; Aspirin; Blood Platelets; Blood Vessels; Dextrans; Diltiazem; Dipyridamole; Epoprostenol; Humans; Imidazoles; Ketanserin; Piperidines; Pyrazoles; Pyrazolones; Sulfinpyrazone; Sulfonamides; Thiophenes; Ticlopidine | 1986 |
Antiplatelet therapy in thrombotic thrombocytopenic purpura.
Topics: Aspirin; Blood Platelets; Dextrans; Dipyridamole; Epoprostenol; Humans; Microcirculation; Platelet Aggregation; Purpura, Thrombotic Thrombocytopenic; Sulfinpyrazone; Ticlopidine | 1987 |
Role of platelet inhibitor therapy in myocardial infarction.
Topics: Aspirin; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Sulfinpyrazone | 1989 |
[Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Topics: Aspirin; Canada; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Dipyridamole; Drug Evaluation; Humans; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Sulfinpyrazone; United States | 1989 |
Secondary prevention of coronary events after myocardial infarction. Beta-blockers and/or anti-platelets: to whom, when and for how long. A review.
Topics: Adrenergic beta-Antagonists; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Sulfinpyrazone | 1985 |
Platelets and prostaglandins in sudden death: therapeutic implications.
Topics: Adrenergic beta-Antagonists; Animals; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Death, Sudden; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Prostaglandins; Risk; Sulfinpyrazone; Thrombosis | 1985 |
Platelets and antiplatelet therapy in ischemic heart disease.
Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Humans; Myocardial Infarction; Platelet Adhesiveness; Sulfinpyrazone; Thromboxanes | 1986 |
[Hypercoagulability and cerebral infarction].
Topics: Aspirin; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cerebral Infarction; Clinical Trials as Topic; Dipyridamole; Glycoproteins; Humans; Platelet Aggregation; Sulfinpyrazone; Suloctidil; Thromboxanes; von Willebrand Factor | 1986 |
Antiplatelet drugs in the management of patients with thrombotic disorders.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets; Catheterization; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Glomerulonephritis; Humans; Sulfinpyrazone; Suloctidil; Thiophenes; Thrombophlebitis; Thrombosis; Ticlopidine; Vascular Diseases; Vascular Surgical Procedures | 1986 |
[Antiplatelet drugs and prevention of aortocoronary bypass occlusion].
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Sulfinpyrazone; Thrombosis; Ticlopidine | 1988 |
Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Follow-Up Studies; Humans; Male; Myocardial Infarction; Random Allocation; Sulfinpyrazone | 1987 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Female; Glomerulonephritis; Graft Occlusion, Vascular; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thiophenes; Ticlopidine | 1986 |
Dose antiplatelet agents; the relationship among side effects, and antithrombotic effectiveness.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Dipyridamole; Dose-Response Relationship, Drug; Epoprostenol; Fibrinolytic Agents; Gastric Mucosa; Humans; Sulfinpyrazone | 1986 |
Antithrombotic agents in coronary artery disease.
Topics: Angina, Unstable; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Sulfinpyrazone; Thromboembolism; Time Factors | 1986 |
[Thrombocyte aggregation inhibitors--a new class of active substances. 2. Chemical and pharmacologic aspects of some agents].
Topics: Anti-Inflammatory Agents; Aspirin; Chemical Phenomena; Chemistry; Dipyridamole; Heterocyclic Compounds; Humans; Imidazoles; Phthalazines; Platelet Aggregation; Pyridazines; Pyridines; Pyrimidines; Quinazolines; Quinolines; Sulfinpyrazone | 1986 |
[Thrombosis in various diseases: arteriosclerosis and thrombosis].
Topics: Animals; Arteriosclerosis; Aspirin; Dipyridamole; Humans; Sulfinpyrazone; Thrombosis | 1986 |
Aspirin and other platelet-aggregation inhibiting drugs.
Topics: Aspirin; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Female; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Kinetics; Male; Platelet Aggregation; Sulfinpyrazone; Thrombophlebitis | 1985 |
Clinical aspects of antiplatelet therapy.
Topics: Angina Pectoris; Aspirin; Blood Coagulation Disorders; Clinical Trials as Topic; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1985 |
The human pharmacology of platelet inhibition: pharmacokinetics relevant to drug action.
Topics: Aspirin; Blood Platelets; Dipyridamole; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; Kinetics; Models, Biological; Sulfinpyrazone; Thromboxane-A Synthase | 1985 |
Management of thrombotic diseases.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Coumarins; Dextrans; Dipyridamole; Drug Antagonism; Drug Hypersensitivity; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Heart Valve Prosthesis; Hemorrhage; Heparin; Histamine H1 Antagonists; Humans; Hydrocortisone; Indenes; Intracranial Embolism and Thrombosis; Iodine Isotopes; Platelet Adhesiveness; Prostaglandins; Reserpine; Rheumatic Heart Disease; Streptokinase; Sulfinpyrazone; Thrombosis | 1971 |
The prevention of thrombosis.
Topics: Anti-Inflammatory Agents; Anticoagulants; Aspirin; Coumarins; Dipyridamole; Heparin; Humans; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1974 |
Platelet inhibition in the management of thrombosis.
Topics: Aspirin; Blindness; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dextrans; Dipyridamole; Fibrinogen; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Iodine Radioisotopes; Molecular Weight; Myocardial Infarction; Phlebography; Renal Dialysis; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Thrombosis | 1974 |
Anticoagulants.
Topics: Anticoagulants; Aspirin; Blood Platelet Disorders; Dipyridamole; Enzyme Therapy; Factor IX; Factor VII; Factor X; Hemolysin Proteins; Hemorrhage; Heparin; Heparin Antagonists; Humans; Infusions, Parenteral; Phenindione; Protamines; Prothrombin; Streptokinase; Sulfinpyrazone; Thrombophlebitis; Thrombosis; Venoms; Warfarin | 1974 |
Anion permeability of the red blood cell.
Topics: Benzoates; Biological Transport; Caprylates; Cell Membrane Permeability; Dicarboxylic Acids; Diffusion; Dinitrophenols; Dipyridamole; Erythrocytes; Gentisates; Hydrogen-Ion Concentration; Hydroquinones; Osmolar Concentration; Phenylbutazone; Phloretin; Phlorhizin; Phosphates; Quaternary Ammonium Compounds; Reserpine; Resorcinols; Salicylates; Sulfates; Sulfinpyrazone; Vasodilator Agents | 1970 |
[Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
Topics: Adrenergic beta-Antagonists; Alprenolol; Anti-Arrhythmia Agents; Aspirin; Dipyridamole; Female; Fibrinolytic Agents; Humans; Male; Myocardial Infarction; Phenprocoumon; Platelet Aggregation; Practolol; Propranolol; Recurrence; Sex Factors; Sulfinpyrazone; Time Factors | 1981 |
Drug therapy of hypertension and ischaemic heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Antihypertensive Agents; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Diuretics; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Sulfinpyrazone | 1981 |
[Prevention of myocardial infarction by chemotherapy].
Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Blood Platelets; Dipyridamole; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Recurrence; Sulfinpyrazone | 1982 |
Changing concepts of pathophysiology, prognosis, and therapy in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aspirin; Coronary Disease; Coronary Vasospasm; Death, Sudden; Dipyridamole; Humans; Monitoring, Physiologic; Myocardial Infarction; Prognosis; Recurrence; Sulfinpyrazone | 1983 |
Antiplatelet agents: rationale and results.
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Animals; Arachidonic Acids; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cerebrovascular Disorders; Collagen; Coronary Disease; Dipyridamole; Female; Heart Valve Prosthesis; Hemostasis; Humans; Intracranial Embolism and Thrombosis; Male; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Sex Factors; Sulfinpyrazone; Thrombosis | 1983 |
Bleeding associated with antithrombotic therapy.
Topics: 4-Hydroxycoumarins; Aspirin; Dextrans; Dipyridamole; Dose-Response Relationship, Drug; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Myocardial Infarction; Risk; Streptodornase and Streptokinase; Sulfinpyrazone; Thrombocytopenia; Thrombosis | 1980 |
Therapy of thrombotic thrombocytopenic purpura: an overview.
Topics: Adrenal Cortex Hormones; Aspirin; Blood Transfusion; Dextrans; Dipyridamole; Humans; Immunosuppressive Agents; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Renal Dialysis; Retrospective Studies; Splenectomy; Sulfinpyrazone | 1981 |
[Role of antiaggregant platelet drugs in thromboembolism].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anti-Bacterial Agents; Aspirin; Cerebrovascular Disorders; Dextrans; Dipyridamole; Humans; Mitral Valve; Platelet Aggregation; Platelet Function Tests; Pyridines; Pyridinolcarbamate; Random Allocation; Sulfinpyrazone; Suloctidil; Thiophenes; Thromboembolism; Ticlopidine | 1981 |
Pharmacology and pharmacokinetics of platelet-active drugs under current clinical investigation.
Topics: Absorption; Animals; Aspirin; Biotransformation; Blood Platelets; Cyclooxygenase Inhibitors; Dipyridamole; Humans; Kinetics; Prostaglandins; Structure-Activity Relationship; Sulfinpyrazone | 1982 |
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Double-Blind Method; Humans; Myocardial Infarction; Postoperative Complications; Sulfinpyrazone; Thromboembolism | 1982 |
Current therapy of cerebrovascular disease.
Topics: Adult; Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Risk; Sulfinpyrazone | 1984 |
[Platelet anti-aggregant drugs and ischemic cardiopathy: evaluation of the effect on platelet aggregation and on antithrombin III].
Topics: Adult; Anticoagulants; Antithrombin III; Arrhythmias, Cardiac; Clofibrate; Dipyridamole; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation; Pyridines; Sulfinpyrazone; Suloctidil; Thiophenes; Ticlopidine | 1981 |
[Pharmacology of anti-platelet agents].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelets; Cyclic AMP; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Female; Fibrinolytic Agents; Humans; In Vitro Techniques; Intestinal Absorption; Kinetics; Male; Papio; Platelet Aggregation; Prostaglandin Antagonists; Rabbits; Sulfinpyrazone; Thiophenes; Thrombosis; Thromboxane A2; Ticlopidine | 1983 |
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Time Factors | 1983 |
Therapeutical aspects of cerebrovascular disease.
Topics: Aspirin; Blood Coagulation; Cerebrovascular Disorders; Clofibrate; Dipyridamole; Erythrocyte Aggregation; Erythrocytes; Humans; Ischemic Attack, Transient; Pentoxifylline; Plasma; Platelet Aggregation; Sulfinpyrazone | 1983 |
Role of platelet-active drugs in coronary artery disease.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Europe; Female; Humans; Male; Myocardial Infarction; Prospective Studies; Research Design; Sulfinpyrazone; Time Factors; United States | 1983 |
Platelet inhibitors for TIAs. A review of prospective drug trial results.
Topics: Aged; Aspirin; Clofibrate; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Platelet Aggregation; Prospective Studies; Recurrence; Sulfinpyrazone | 1984 |
Platelets, carotids, and coronaries. Critique on antithrombotic role of antiplatelet agents, exercise, and certain diets.
Topics: Angina Pectoris; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Carotid Artery Thrombosis; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Endothelium; Exercise Therapy; Female; Humans; Ischemic Attack, Transient; Life Style; Male; Platelet Aggregation; Sex Factors; Sulfinpyrazone | 1984 |
[Current clinical results of antiplatelet medication].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelets; Brain Ischemia; Coronary Disease; Dipyridamole; Drug Evaluation; Heart Valve Prosthesis; Humans; Myocardial Infarction; Platelet Aggregation; Platelet Function Tests; Postoperative Complications; Rabbits; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Vascular Surgical Procedures | 1984 |
[Blood platelets and myocardial infarction].
Topics: Aspirin; Blood Platelets; Dipyridamole; Epoprostenol; Humans; Myocardial Infarction; Platelet Aggregation; Prostaglandins, Synthetic; Sulfinpyrazone; Thromboxane A2 | 1984 |
Efficacy of antiplatelet drugs in the maintenance of aortocoronary vein bypass graft patency.
Topics: Animals; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Dipyridamole; Humans; Saphenous Vein; Sulfinpyrazone | 1983 |
Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
Topics: Animals; Anticoagulants; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Female; Humans; In Vitro Techniques; Male; Placebos; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1980 |
[Prevention of thrombosis by thrombocyte inhibition. 2. Clinical results].
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofibrate; Dextrans; Dipyridamole; Humans; Kidney Diseases; Sulfinpyrazone; Thrombosis | 1980 |
[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
Topics: Anticoagulants; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Flurbiprofen; Humans; Hydroxychloroquine; Lidocaine; Platelet Aggregation; Postoperative Complications; Pulmonary Embolism; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1980 |
Platelet-active drugs in the secondary prevention of cardiovascular events: an overview.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Coronary Disease; Dipyridamole; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1980 |
Antithrombotic drugs in relation to prostaglandin metabolism.
Topics: Aspirin; Coronary Disease; Dipyridamole; Extracorporeal Circulation; Fibrinolytic Agents; Heparin; Humans; Inuit; Platelet Aggregation; Prostaglandins; Sulfinpyrazone; Thromboembolism | 1980 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Sex Factors; Sulfinpyrazone | 1981 |
10. Antithrombotic therapy: role of platelet-inhibitor drugs. II. Pharmacologic effects of platelet-inhibitor drugs (second of three parts).
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Fibrinolytic Agents; Gastrointestinal Diseases; Humans; Platelet Aggregation; Prostaglandins; Sulfinpyrazone; Thrombosis | 1981 |
[Myocardial infarct: secondary prevention with drugs and their effects].
Topics: Alprenolol; Aspirin; Dipyridamole; Humans; Myocardial Infarction; Prognosis; Sulfinpyrazone | 1980 |
[Platelet antiaggregants and arteriopathies].
Topics: Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1981 |
Antiplatelet therapy.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Heart Valve Diseases; Humans; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1981 |
Myocardial infarction.
Topics: Anticoagulants; Aspirin; Blood Platelets; Death, Sudden; Dipyridamole; Fibrinolytic Agents; Humans; Myocardial Infarction; Sulfinpyrazone | 1981 |
Antiplatelet agents: their role in the prevention of sudden death.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Clinical Trials as Topic; Coronary Circulation; Coronary Disease; Death, Sudden; Dipyridamole; Dogs; Endothelium; Humans; Male; Muscle, Smooth; Myocardial Infarction; Papio; Platelet Adhesiveness; Prostaglandins; Rabbits; Sulfinpyrazone | 1982 |
[Platelets and prostaglandins in ischemic cardiopathy. Theoretical and practical aspects and research prospects].
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Humans; Platelet Aggregation; Platelet Count; Prostaglandins; Sulfinpyrazone; Thromboxanes | 1982 |
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Heart Diseases; Humans; Hydroxychloroquine; Neoplasms; Sulfinpyrazone; Thromboembolism; Thrombosis | 1982 |
Use of cumulative meta-analysis in the design, monitoring, and final analysis of a clinical trial: a case study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Protocols; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Humans; Meta-Analysis as Topic; Placebos; Platelet Aggregation Inhibitors; Saphenous Vein; Sulfinpyrazone; Uricosuric Agents | 1995 |
64 trial(s) available for sulfinpyrazone and dipyridamole
| Article | Year |
|---|---|
Role of blood platelets in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Evaluation; Humans; Myocardial Infarction; Placebos; Platelet Aggregation; Prostaglandins, Synthetic; Spasm; Sulfinpyrazone | 1979 |
[Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy].
Topics: Adult; Anticoagulants; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy; Early Ambulation; Exercise Therapy; Fibrinogen; Fibrinolysis; Heparin; Humans; Myocardial Infarction; Physical Therapy Modalities; Platelet Aggregation; Postoperative Complications; Posture; Pulmonary Embolism; Streptokinase; Sulfinpyrazone; Thromboembolism; Thrombosis | 1975 |
Guidelines for the management of transient ischemic attacks.
Topics: Anticoagulants; Aspirin; Blood Platelets; Carotid Arteries; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Endarterectomy; Humans; Ischemic Attack, Transient; Placebos; Sulfinpyrazone | 1978 |
[Clinical application and evaluation of anti-platelet agents].
Topics: Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Female; Humans; Intracranial Embolism and Thrombosis; Male; Myocardial Infarction; Prostheses and Implants; Sulfinpyrazone; Thrombophlebitis | 1978 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thromboembolism; Thrombosis | 1978 |
Does aspirin prevent stroke?
Topics: Anticoagulants; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Drug Interactions; Female; Health Promotion; Humans; Ischemic Attack, Transient; Male; Sulfinpyrazone | 1979 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Kidney Diseases; Kidneys, Artificial; Male; Silicone Elastomers; Sulfinpyrazone; Thromboembolism; Thrombosis; Vascular Diseases | 1975 |
Clinical trials in thrombosis: secondary prevention of myocardial infarction.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Myocardial Infarction; Prospective Studies; Sulfinpyrazone; Thromboembolism | 1976 |
The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
Topics: Adenosine Diphosphate; Animals; Aspirin; Blood Platelets; Clinical Trials as Topic; Collagen; Dipyridamole; Female; Male; Platelet Adhesiveness; Platelet Aggregation; Rabbits; Sulfinpyrazone; Thrombophlebitis; Tromethamine | 1975 |
The current status of platelet suppressive drugs in the treatment of thrombosis.
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cardiac Catheterization; Cell Survival; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Myocardial Infarction; Postoperative Complications; Renal Dialysis; Sulfinpyrazone; Thrombocytosis; Thromboembolism | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Prospective Studies; Pyrimidines; Retrospective Studies; Sulfinpyrazone; Thromboembolism; Warfarin | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Graft Rejection; Humans; Kidney Transplantation; Male; Myocardial Infarction; Sulfinpyrazone; Thromboembolism; Thrombosis; Transplantation, Homologous | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Fibrinolytic Agents; Humans; Hydroxychloroquine; Postoperative Complications; Pulmonary Embolism; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Thrombosis | 1975 |
[Anticoagulant or antiplatelet aggregation treatment after aortocoronary bypass].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Sulfinpyrazone; Ticlopidine; Vitamin K | 1991 |
[Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"].
Topics: Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Middle Aged; Prognosis; Sulfinpyrazone | 1990 |
Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy.
Topics: Aspirin; Blood Transfusion; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Graft Occlusion, Vascular; Hemorrhage; Humans; Male; Middle Aged; Premedication; Randomized Controlled Trials as Topic; Reoperation; Sulfinpyrazone; Vascular Patency | 1990 |
Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Graft Occlusion, Vascular; Humans; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Saphenous Vein; Sulfinpyrazone; Time Factors; Vascular Patency | 1989 |
[Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Topics: Aspirin; Canada; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Dipyridamole; Drug Evaluation; Humans; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Sulfinpyrazone; United States | 1989 |
Platelets and antiplatelet therapy in ischemic heart disease.
Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Humans; Myocardial Infarction; Platelet Adhesiveness; Sulfinpyrazone; Thromboxanes | 1986 |
[Hypercoagulability and cerebral infarction].
Topics: Aspirin; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cerebral Infarction; Clinical Trials as Topic; Dipyridamole; Glycoproteins; Humans; Platelet Aggregation; Sulfinpyrazone; Suloctidil; Thromboxanes; von Willebrand Factor | 1986 |
Platelet-inhibitory therapy in reconstructive arterial surgery.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Sulfinpyrazone; Thrombosis | 1985 |
Antiplatelet agents in the secondary prevention of stroke: meta-analysis of the randomized control trials.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Random Allocation; Sulfinpyrazone | 1988 |
Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Follow-Up Studies; Humans; Male; Myocardial Infarction; Random Allocation; Sulfinpyrazone | 1987 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Female; Glomerulonephritis; Graft Occlusion, Vascular; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thiophenes; Ticlopidine | 1986 |
Dose antiplatelet agents; the relationship among side effects, and antithrombotic effectiveness.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Dipyridamole; Dose-Response Relationship, Drug; Epoprostenol; Fibrinolytic Agents; Gastric Mucosa; Humans; Sulfinpyrazone | 1986 |
Antithrombotic agents in coronary artery disease.
Topics: Angina, Unstable; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Sulfinpyrazone; Thromboembolism; Time Factors | 1986 |
Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrinolytic Agents; Graft Occlusion, Vascular; Heparin; Humans; Platelet Aggregation; Saphenous Vein; Sulfinpyrazone; Thiophenes; Ticlopidine | 1986 |
[Secondary prevention of ischemic heart disease. Evaluation of platelet function in patients treated with anticoagulants and cod liver oil].
Topics: Adult; Aged; Anticoagulants; Aspirin; Clinical Trials as Topic; Cod Liver Oil; Coronary Disease; Dipyridamole; Fish Oils; Humans; Middle Aged; Platelet Aggregation; Recurrence; Sulfinpyrazone | 1986 |
A critical appraisal of the clinical efficiency of anti-platelet drugs.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Double-Blind Method; Hemorrhage; Humans; Myocardial Revascularization; Prospective Studies; Sulfinpyrazone; Thromboxanes | 1986 |
Clinical aspects of antiplatelet therapy.
Topics: Angina Pectoris; Aspirin; Blood Coagulation Disorders; Clinical Trials as Topic; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1985 |
[Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct].
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Fibrinolytic Agents; Humans; Myocardial Infarction; Platelet Aggregation; Recurrence; Sulfinpyrazone | 1985 |
Secondary prevention of myocardial infarction.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Myocardial Infarction; Random Allocation; Sulfinpyrazone | 1985 |
[Eicosanoids, myocardial ischemia and sudden death].
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Coronary Disease; Cyclooxygenase Inhibitors; Death, Sudden; Dipyridamole; Dogs; Epoprostenol; Hemodynamics; Humans; Myocardial Infarction; Random Allocation; Sulfinpyrazone | 1985 |
A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
Topics: Adrenergic beta-Antagonists; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Death, Sudden; Dipyridamole; Female; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Risk; Sulfinpyrazone; Thrombophlebitis | 1980 |
Prophylaxis of myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Myocardial Infarction; Sulfinpyrazone; Timolol | 1981 |
Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.
Topics: Acetylation; Aspirin; Blood Platelets; Blood Vessels; Clinical Trials as Topic; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Thrombosis; Thromboxane-A Synthase | 1982 |
[Aftercare of heart infarct patients to reduce the risk of a subsequent infarction].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Hypolipidemic Agents; Myocardial Infarction; Patient Care Planning; Platelet Aggregation; Recurrence; Risk; Sulfinpyrazone; Thiophenes; Ticlopidine | 1983 |
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Double-Blind Method; Humans; Myocardial Infarction; Postoperative Complications; Sulfinpyrazone; Thromboembolism | 1982 |
Platelet tests and antiplatelet drugs in coronary artery disease.
Topics: Adult; Aspirin; beta-Thromboglobulin; Blood Platelets; Cell Survival; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Platelet Function Tests; Random Allocation; Sulfinpyrazone | 1983 |
[Critical approach to a therapeutic trial in secondary prevention of cerebral ischemic accidents by antiaggregants].
Topics: Adult; Aged; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Dihydroergotoxine; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation; Sulfinpyrazone | 1983 |
[Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
Topics: Adult; Aged; Anticoagulants; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Female; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation; Sulfinpyrazone | 1983 |
Platelets and prostaglandins in coronary artery disease. Rationale for use of platelet-suppressive drugs.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Dogs; Humans; Models, Biological; Platelet Aggregation; Prostaglandins; Sulfinpyrazone | 1983 |
Pharmacological trials: primary and secondary prevention of coronary heart disease.
Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dipyridamole; Estrogens; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Sulfinpyrazone | 1983 |
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Time Factors | 1983 |
Role of platelet-active drugs in coronary artery disease.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Europe; Female; Humans; Male; Myocardial Infarction; Prospective Studies; Research Design; Sulfinpyrazone; Time Factors; United States | 1983 |
Prevention of stroke.
Topics: Aged; Aspirin; Canada; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Female; Heparin; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Placebos; Platelet Aggregation; Random Allocation; Risk; Sex Factors; Sulfinpyrazone; United States; Warfarin | 1984 |
Efficacy of antiplatelet drugs in the maintenance of aortocoronary vein bypass graft patency.
Topics: Animals; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Dipyridamole; Humans; Saphenous Vein; Sulfinpyrazone | 1983 |
Plasma factor and platelet sensitivity to prostacyclin in patients with peripheral vascular disease before and after treatment with a combination of a cyclooxygenase and a phosphodiesterase inhibitor.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Humans; Male; Phosphodiesterase Inhibitors; Sulfinpyrazone; Vascular Diseases | 1984 |
[Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Recurrence; Sulfinpyrazone | 1982 |
Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
Topics: Animals; Anticoagulants; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Female; Humans; In Vitro Techniques; Male; Placebos; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1980 |
Aspirin and recurrent myocardial infarction.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Recurrence; Sex Factors; Sulfinpyrazone | 1980 |
Secondary prevention of myocardial infarction--the present state of the ART.
Topics: Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Dipyridamole; Humans; Myocardial Infarction; Recurrence; Sulfinpyrazone; Thrombosis | 1980 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Sex Factors; Sulfinpyrazone | 1981 |
Series on pharmacology in practice. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. III. Management of arterial thromboembolic and atherosclerotic disease (third of three parts).
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Sulfinpyrazone; Thromboembolism; Thrombosis | 1981 |
[Platelet antiaggregants: review of the literature (author's transl)].
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1981 |
[Platelets and coronary artery disease (CAD) (author's transl)].
Topics: Animals; Aspirin; Autopsy; Blood Platelets; Cardiomyopathies; Cell Wall; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Heparin Antagonists; Humans; Platelet Aggregation; Risk; Sulfinpyrazone | 1980 |
Drug trials in prevention of occlusion of aorta--coronary artery vein grafts.
Topics: Angiography; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Humans; Postoperative Care; Random Allocation; Risk; Sulfinpyrazone; Thrombosis; Veins; Warfarin | 1982 |
Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Collagen; Coronary Disease; Dipyridamole; Evaluation Studies as Topic; Humans; Myocardial Infarction; Platelet Aggregation; Prostaglandins; Recurrence; Sulfinpyrazone; Thromboxanes | 1981 |
E.P.S.I.M., the French oral anticoagulant--aspirin trial in post-myocardial infarction patients: design, organization and quality control procedures.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Aspirin; Clinical Trials as Topic; Data Collection; Dipyridamole; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Prognosis; Random Allocation; Recurrence; Sulfinpyrazone | 1981 |
Antiplatelet agents: their role in the prevention of sudden death.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Clinical Trials as Topic; Coronary Circulation; Coronary Disease; Death, Sudden; Dipyridamole; Dogs; Endothelium; Humans; Male; Muscle, Smooth; Myocardial Infarction; Papio; Platelet Adhesiveness; Prostaglandins; Rabbits; Sulfinpyrazone | 1982 |
[Thrombosis prevention with thrombocyte aggregation inhibitors in the venous system].
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Thrombophlebitis | 1982 |
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Heart Diseases; Humans; Hydroxychloroquine; Neoplasms; Sulfinpyrazone; Thromboembolism; Thrombosis | 1982 |
Antiplatelet therapy and cerebrovascular diseases.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Humans; Sulfinpyrazone | 1982 |
Use of cumulative meta-analysis in the design, monitoring, and final analysis of a clinical trial: a case study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Protocols; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Humans; Meta-Analysis as Topic; Placebos; Platelet Aggregation Inhibitors; Saphenous Vein; Sulfinpyrazone; Uricosuric Agents | 1995 |
145 other study(ies) available for sulfinpyrazone and dipyridamole
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Antiplatelet drugs in a rat microsurgical model of arterial thrombosis.
Topics: Animals; Aspirin; Blood Coagulation; Blood Platelets; Carotid Artery Thrombosis; Dipyridamole; Disease Models, Animal; Hydrogen-Ion Concentration; Male; Polyethylene Glycols; Rats; Sodium Chloride; Sulfinpyrazone | 1979 |
Increase of platelet prostaglandin cyclic endoperoxides in thrombosis.
Topics: Blood Platelets; Clofibrate; Collagen; Dipyridamole; Heparin; Humans; Peroxides; Prospective Studies; Prostaglandins; Prostaglandins F; Pyridines; Sulfinpyrazone; Thiophenes; Thrombophlebitis; Thrombosis | 1977 |
Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Blood Transfusion; Dipyridamole; Disease Models, Animal; Femoral Artery; Femoral Vein; Fibrinogen; Haplorhini; Heparin; Kidney; Male; Papio; Platelet Adhesiveness; Polyurethanes; Regional Blood Flow; Silicone Elastomers; Sulfinpyrazone; Thromboembolism | 1979 |
Effects of inhibitors of platelets aggregation on oxidative phosphorylation in rat liver mitochondria in vitro.
Topics: Adenosine Triphosphatases; Animals; Aspirin; Dipyridamole; In Vitro Techniques; Male; Mitochondria, Liver; Nicergoline; Oxidative Phosphorylation; Oxygen Consumption; Platelet Aggregation; Rats; Sulfinpyrazone | 1979 |
In vitro evaluation of inhibitors of platelet release and aggregation.
Topics: Adenosine; Adenosine Diphosphate; Anti-Inflammatory Agents; Antilymphocyte Serum; Aspirin; Blood Platelets; Collagen; Depression, Chemical; Dextrans; Dipyridamole; Epinephrine; Hematology; Humans; Molecular Weight; Phosphoric Monoester Hydrolases; Platelet Adhesiveness; Platelet Aggregation; Propionates; Prostaglandins E; Serotonin; Sulfinpyrazone; T-Lymphocytes | 1975 |
Platelet release and aggregation induced by antithymocyte globulin. In vitro effect of inhibitors.
Topics: Adenosine; Antilymphocyte Serum; Apyrase; Aspirin; Blood Platelets; Dipyridamole; Flurbiprofen; Humans; Phosphoric Monoester Hydrolases; Platelet Aggregation; Propionates; Prostaglandins E; Sulfinpyrazone; T-Lymphocytes | 1975 |
Evaluation of antiinflammatory and antithrombotic drugs in pulmonary and arterial thrombosis.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Anti-Inflammatory Agents; Arterial Occlusive Diseases; Aspirin; Benzophenones; Carotid Arteries; Cattle; Dipyridamole; Drug Evaluation; Fibrinolytic Agents; Humans; Imidazoles; Indoles; Indomethacin; Lung Diseases, Obstructive; Male; Mice; Platelet Aggregation; Prostaglandins; Pyridines; Quinazolines; Rats; Sulfinpyrazone; Sulfonamides; Suloctidil; Thiophenes | 1979 |
[Anti-platelet aggregating drugs in the prevention of thromboembolic diseases].
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Cardiovascular Diseases; Cerebrovascular Disorders; Chromonar; Dextrans; Dipyridamole; Histamine H1 Antagonists; Humans; Kidney Diseases; Platelet Adhesiveness; Platelet Aggregation; Pyrimidines; Sulfinpyrazone; Thromboembolism; Thrombosis; Tranquilizing Agents | 1975 |
Treating thromboembolic disease.
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Heparin; Humans; Ischemic Attack, Transient; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1977 |
Platelet-suppressant therapy in patients with coronary artery disease.
Topics: Adult; Blood Platelets; Cell Survival; Clofibrate; Coronary Artery Bypass; Coronary Disease; Death, Sudden; Dipyridamole; Humans; Male; Middle Aged; Saphenous Vein; Sulfinpyrazone; Transplantation, Autologous | 1978 |
[Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cerebral Infarction; Cerebrovascular Disorders; Dipyridamole; Heparin; Humans; Ischemic Attack, Transient; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1979 |
[Therapy and prevention of acute phlebothrombosis with heparin, coumarins and inhibitors of platelet function].
Topics: Coumarins; Dextrans; Dipyridamole; Dose-Response Relationship, Drug; Heparin; Humans; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1979 |
Transient ischemic attacks due to increased platelet aggregation and adhesiveness. Ultrastructural and functional correlation.
Topics: Adolescent; Adult; Aspirin; Blood Coagulation Tests; Blood Platelet Disorders; Blood Platelets; Dipyridamole; Female; Hemostasis; Humans; Ischemic Attack, Transient; Male; Microscopy, Electron, Scanning; Middle Aged; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone | 1979 |
[Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
Topics: Anticoagulants; Aspirin; Coronary Disease; Dipyridamole; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1979 |
Status of antiplatelet drugs in coronary heart disease.
Topics: Aspirin; Blood Platelets; Clofibrate; Coronary Disease; Dipyridamole; Humans; Male; Models, Biological; Platelet Aggregation; Propranolol; Sulfinpyrazone | 1979 |
Antithrombotic activity of glycosaminoglycans of mammalian origin. In vivo experiments in the rabbit.
Topics: Animals; Collagen; Dipyridamole; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Male; Rabbits; Sulfinpyrazone; Time Factors | 1979 |
Is the antithrombotic activity of "antiplatelet" drugs based on protection of endothelium?
Topics: Animals; Aspirin; Citrates; Clofibrate; Dipyridamole; Endothelium; Female; Hydroxychloroquine; Platelet Aggregation; Rats; Sulfinpyrazone | 1979 |
[Inhibitors of platelet aggregation in the therapy of arteriosclerosis obliterans].
Topics: Arteriosclerosis Obliterans; Aspirin; Diabetic Angiopathies; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1979 |
[Relationship between inhibitory effect of anti-platelet drugs on platelet aggregation and clinical value (author's transl)].
Topics: Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1979 |
The effect of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo.
Topics: Animals; Aspirin; Blood Coagulation; Blood Platelets; Dipyridamole; Fibrinolytic Agents; Flurbiprofen; Heparin; Magnesium Sulfate; Morpholines; Pyrimidines; Rabbits; Sulfinpyrazone | 1979 |
Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood.
Topics: Animals; Aspirin; Blood Platelets; Blood Vessels; Citrates; Dipyridamole; Dose-Response Relationship, Drug; Endothelium; Female; Male; Platelet Adhesiveness; Platelet Aggregation; Rabbits; Sulfinpyrazone; Thrombosis | 1979 |
[Antiplatelet drugs (author's transl)].
Topics: Aspirin; Blood Platelets; Clofibrate; Dipyridamole; Female; Humans; Hydroxychloroquine; Ischemic Attack, Transient; Male; Myocardial Infarction; Nicergoline; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1979 |
[Inhibition of platelet aggregation by platelet inhibitory agents and its relation to their clinical effects].
Topics: Depression, Chemical; Dipyridamole; Dose-Response Relationship, Drug; Humans; Phthalazines; Platelet Aggregation; Pyridazines; Quinolines; Quinolones; Sulfinpyrazone; Thrombosis | 1979 |
Antiplatelet treatment of thrombotic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Aspirin; Blood Platelets; Cyproheptadine; Dextrans; Dipyridamole; Female; Humans; Male; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Splenectomy; Sulfinpyrazone | 1977 |
Platelet-latelet-.
Topics: Adult; Aspirin; Blood Platelets; Depression, Chemical; Dipyridamole; Female; Humans; Methylprednisolone; Middle Aged; Prednisone; Purpura, Thrombotic Thrombocytopenic; Remission, Spontaneous; Sulfinpyrazone | 1977 |
Thrombotic thrombocytopenic purpura: failure of plasma infusion and antiplatelet agents.
Topics: Adult; Aspirin; Blood Platelets; Dipyridamole; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Plasmapheresis; Prednisone; Purpura, Thrombotic Thrombocytopenic; Sulfinpyrazone | 1979 |
The retired breeder rat as a new model for antiplatelet drug discovery.
Topics: Animals; Aspirin; Breeding; Dipyridamole; Male; Platelet Aggregation; Prostaglandins E; Rats; Sulfinpyrazone | 1977 |
Assessment of antithrombotic drugs ex vivo and in vivo.
Topics: Animals; Aspirin; Citrates; Collagen; Dipyridamole; Fibrinolytic Agents; Heparin; Platelet Aggregation; Rabbits; Sulfinpyrazone | 1977 |
[Platelet-inhibiting drugs].
Topics: Anti-Bacterial Agents; Aspirin; Dextrans; Dipyridamole; Hemorrhage; Humans; Indomethacin; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1978 |
Antiplatelet therapy (first of two parts).
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Blood Coagulation; Blood Platelets; Cell Survival; Clofibrate; Dextrans; Dipyridamole; Heparin; Humans; Platelet Adhesiveness; Platelet Aggregation; Propranolol; Rabbits; Sulfinpyrazone; Thrombosis | 1978 |
Antiplatelet agents in coronary disease: are they of prophylactic value?
Topics: Angina Pectoris; Aspirin; Cardiopulmonary Bypass; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Myocardial Infarction; Recurrence; Sulfinpyrazone | 1978 |
[Results of clinical studies on the effect of aggregation inhibitors in arterial diseases].
Topics: Arterial Occlusive Diseases; Aspirin; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1979 |
Antithrombotic therapy. Rationale and application.
Topics: Anticoagulants; Arteries; Arteriosclerosis; Aspirin; Blood Coagulation; Blood Coagulation Factors; Dipyridamole; Fibrinolytic Agents; Humans; Platelet Adhesiveness; Sulfinpyrazone; Thrombophlebitis; Thrombosis; Urokinase-Type Plasminogen Activator; Veins; Warfarin | 1979 |
[Prophylaxis and therapy of shunt thrombosis in terminal renal insufficiency (author's transl)].
Topics: Anticoagulants; Arteriovenous Shunt, Surgical; Aspirin; Dextrans; Dipyridamole; Hemorrhagic Disorders; Heparin; Humans; Renal Dialysis; Sulfinpyrazone; Thrombosis; Uremia | 1977 |
Effects of sulphinpyrazone and dipyridamole on capillary bleeding time in man.
Topics: Blood Cell Count; Blood Coagulation; Blood Platelets; Dipyridamole; Double-Blind Method; Humans; Platelet Aggregation; Sulfinpyrazone | 1977 |
Anticoagulants and platelet-inhibiting drugs in stroke.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1977 |
Effect of drugs of platelets and complications of vascular disease.
Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Clofibrate; Coronary Disease; Death, Sudden; Dipyridamole; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1977 |
Using antithrombotic therapy in ischemic cerebrovascular disease.
Topics: Aspirin; Brain; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Intracranial Embolism and Thrombosis; Ischemia; Sulfinpyrazone; Warfarin | 1977 |
Platelets, thrombosis and atherosclerosis.
Topics: Arteries; Arteriosclerosis; Aspirin; Blood Platelets; Cell Division; Cell Survival; Dipyridamole; Endothelium; Humans; Platelet Adhesiveness; Sulfinpyrazone; Thrombosis | 1977 |
[Pharmacology of aggregation inhibitors].
Topics: Aspirin; Dextrans; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1976 |
Use of platelet antagonists in the treatment of migraine.
Topics: Aspirin; Blood Platelets; Dipyridamole; Migraine Disorders; Platelet Aggregation; Sulfinpyrazone | 1976 |
Registry of prospective clinical trials second report.
Topics: Adult; Aged; Aspirin; Blood Platelets; Dipyridamole; Drug Evaluation; Female; Fibrinolytic Agents; Hemostatics; Humans; International Agencies; Male; Middle Aged; Plasminogen; Registries; Streptokinase; Sulfinpyrazone; Urokinase-Type Plasminogen Activator; Venoms | 1976 |
Are agents affecting platelet function clinically useful in patients with coronary artery disease?
Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Clofibrate; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Sulfinpyrazone | 1976 |
Platelet survival time following aortic valve replacement.
Topics: Adult; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Aspirin; Blood Platelets; Cell Survival; Chromium Radioisotopes; Dipyridamole; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Sulfinpyrazone; Thromboembolism; Time Factors; Transplantation, Autologous; Warfarin | 1975 |
Letter: Medical management of transient ischaemic attacks.
Topics: Anti-Inflammatory Agents; Anticoagulants; Aspirin; Dipyridamole; Humans; Ischemic Attack, Transient; Sulfinpyrazone | 1975 |
[Special pharmacotherapy of primary glomerulonephritis in the adult].
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Anticoagulants; Azathioprine; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Glomerulonephritis; Heparin; Humans; Indomethacin; Nephrotic Syndrome; Prednisone; Sulfinpyrazone | 1975 |
Proceedings: Comparative effects of platelet suppressant drugs on platelet survival time.
Topics: Blood Platelets; Cell Survival; Clofibrate; Dipyridamole; Humans; In Vitro Techniques; Sulfinpyrazone; Thromboembolism | 1975 |
Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Dipyridamole; In Vitro Techniques; Platelet Aggregation; Rabbits; Sulfinpyrazone; Thromboembolism | 1975 |
Pharmacological properties of drug inhibiting platelet aggregation.
Topics: Aspirin; Dipyridamole; Humans; In Vitro Techniques; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1975 |
Clinical pharmacology of anti-aggregating substances.
Topics: Aspirin; Clofibrate; Dextrans; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1975 |
[Strategies for antiplatelet therapy-drug-fixed method and suppression-fixed method].
Topics: Aspirin; Cerebral Infarction; Dipyridamole; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Aggregation; Recurrence; Sulfinpyrazone; Ticlopidine | 1992 |
Human equivalent doses of platelet inhibitors and experimental atherosclerosis.
Topics: Animals; Aorta; Arteriosclerosis; Aspirin; Blood Platelets; Dipyridamole; Dose-Response Relationship, Drug; Rabbits; Sulfinpyrazone | 1990 |
Antiplatelet therapy to prevent coronary artery bypass graft occlusion.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Combinations; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Sulfinpyrazone | 1990 |
Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Clofibrate; Coronary Disease; Dextrothyroxine; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Estrogens; Humans; Hypertension; Myocardial Infarction; Niacin; Sulfinpyrazone | 1985 |
[Antiaggregants of thrombocytes in ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Aspirin; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Humans; Molsidomine; Nitroprusside; Platelet Aggregation; Sulfinpyrazone; Sydnones; Verapamil | 1985 |
A sensitive model of venous thrombosis in rats.
Topics: Animals; Anticoagulants; Aspirin; Dipyridamole; Disease Models, Animal; Female; Heparin; Ketanserin; Piperidines; Rats; Rats, Inbred Strains; Sulfinpyrazone; Thrombophlebitis; Time Factors | 1986 |
Antithrombotics in view of thrombosis models.
Topics: Animals; Anticoagulants; Arteries; Aspirin; Dipyridamole; Female; Hydroxyethylrutoside; Ketanserin; Piperidines; Pizotyline; Prenylamine; Rats; Rats, Inbred Strains; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1986 |
[Secondary prevention of peripheral arterial occlusive diseases].
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Coumarins; Dipyridamole; Humans; Sulfinpyrazone | 1987 |
Anti-platelet agents reduce morphological changes of chronic hypoxic pulmonary hypertension.
Topics: Animals; Dipyridamole; Flunarizine; Heart; Heart Ventricles; Hypertension, Pulmonary; Hypoxia; Male; Myocardium; Platelet Aggregation Inhibitors; Pulmonary Artery; Rats; Rats, Inbred Strains; Sulfinpyrazone | 1987 |
Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Arginine; Argininosuccinic Acid; Blood Platelets; Breast Neoplasms; Creatinine; Dipyridamole; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Plasmapheresis; Sulfinpyrazone; Tablets, Enteric-Coated; Time Factors | 1986 |
Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Combinations; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Random Allocation; Sulfinpyrazone | 1988 |
Platelet-inhibitor therapy in cardiovascular disease. Effective defense against thromboembolism.
Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Bioprosthesis; Blood Platelets; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Graft Occlusion, Vascular; Heart Valve Prosthesis; Heparin; Humans; Prothrombin Time; Random Allocation; Sulfinpyrazone; Thromboembolism; Time Factors; Warfarin | 1985 |
[Anti-aggregation therapy of patients with ischemic heart disease].
Topics: Aspirin; Coronary Disease; Dipyridamole; Drug Evaluation; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Sulfinpyrazone; Ticlopidine | 1988 |
Effective antiplatelet drug concentrations in experimental arterial thromboembolism.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Dipyridamole; Kinetics; Male; Papio; Sulfinpyrazone; Thromboembolism | 1987 |
[Role of platelet anti-aggregants in cardiovascular surgery].
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Platelet Aggregation; Sulfinpyrazone; Ticlopidine | 1987 |
[Mode of action and clinical evaluation of platelet aggregation inhibitors].
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Graft Occlusion, Vascular; Humans; Ketanserin; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Ticlopidine | 1987 |
Platelet aggregation and atherosclerosis.
Topics: Arteriosclerosis; Aspirin; Dipyridamole; Electrocardiography; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone | 1986 |
[Prevention and medical treatment of polyregional vascular lesions].
Topics: Adult; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Diet; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Risk; Sulfinpyrazone; Thiophenes; Thrombosis; Ticlopidine | 1985 |
Fulminant gangrene in transient cold agglutinemia associated with Escherichia coli infection.
Topics: Anemia, Hemolytic, Autoimmune; Cryoglobulins; Cytotoxicity, Immunologic; Dipyridamole; Endocarditis, Bacterial; Escherichia coli Infections; Female; Gangrene; Humans; Immunoglobulin G; Immunoglobulin M; Middle Aged; Plasmapheresis; Prednisone; Pyelonephritis; Sulfinpyrazone | 1985 |
Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Cyclooxygenase Inhibitors; Dipyridamole; Drug Synergism; Femoral Artery; Fibrinolytic Agents; Imidazoles; Male; Papio; Sulfinpyrazone; Thromboembolism | 1985 |
Antiplatelet aggregators inhibit development of stress ulcers in Sprague-Dawley rats.
Topics: Animals; Anticoagulants; Aspirin; Capillaries; Dipyridamole; Gastric Mucosa; Male; Platelet Aggregation; Pyridines; Rats; Rats, Inbred Strains; Stomach Ulcer; Stress, Physiological; Sulfinpyrazone; Thiophenes; Thrombosis; Ticlopidine | 1985 |
[Site of action of anticoagulant drugs].
Topics: Administration, Oral; Anticoagulants; Aspirin; Dipyridamole; Hemostasis; Heparin; Humans; Sulfinpyrazone | 1985 |
The influence of antiplatelet drugs on injury-stimulated migration of cultured smooth muscle cells.
Topics: Animals; Arteriosclerosis; Aspirin; Catheterization; Cell Movement; Cells, Cultured; Dipyridamole; Hypophysectomy; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; Sulfinpyrazone | 1985 |
Drug-related changes in platelet shape in whole blood.
Topics: Blood Platelets; Dipyridamole; Humans; Male; Platelet Aggregation; Sulfinpyrazone | 1985 |
[Species specific difference in binding to plasma proteins].
Topics: Aminobenzoates; Aniline Compounds; Animals; Barbiturates; Blood Proteins; Cattle; Chlorpromazine; Dipyridamole; Dogs; Guanidines; Guinea Pigs; Hexobarbital; Methohexital; Mice; Nitrofurantoin; Pentobarbital; Phenylbutazone; Protein Binding; Rabbits; Rats; Salicylamides; Salicylates; Species Specificity; Sulfadimethoxine; Sulfaguanidine; Sulfinpyrazone; Sulfonamides; Swine; Thiopental | 1967 |
Effect of antilymphocyte globulin on platelets.
Topics: Antilymphocyte Serum; Aspirin; Blood Platelets; Cross Reactions; Dipyridamole; Flurbiprofen; Humans; Platelet Aggregation; Prostaglandins E; Serotonin; Sulfinpyrazone | 1974 |
Rapidly progressive glomerulonephritis treated with anticoagulants.
Topics: Adult; Aged; Anticoagulants; Azathioprine; Blood Urea Nitrogen; Creatinine; Dipyridamole; Diuresis; Fibrinolytic Agents; Fluorescent Antibody Technique; Glomerulonephritis; Hemorrhage; Heparin; Humans; Kidney; Middle Aged; Phenindione; Prednisone; Proteinuria; Sulfinpyrazone; Warfarin | 1972 |
Platelets.
Topics: Aspirin; Blood Platelets; Dipyridamole; Humans; Sulfinpyrazone; Thromboembolism | 1973 |
Address of the president-elect: the indication for various methods of treatment of occlusive cerebrovascular disease.
Topics: Anticoagulants; Aspirin; Blood Pressure; Cardiac Output; Carotid Arteries; Cerebral Angiography; Cerebrovascular Circulation; Cerebrovascular Disorders; Dipyridamole; Electroencephalography; Giant Cell Arteritis; Humans; Intracranial Arteriosclerosis; Intracranial Embolism and Thrombosis; Ischemic Attack, Transient; Methods; Neurologic Examination; Polycythemia; Radionuclide Imaging; Sulfinpyrazone | 1973 |
The filter loop technique as a method of measuring platelet aggregation in the flowing blood of the rat; the inhibitory activity of 5-oxo-1-cyclopentene-1-heptanoic acid (AY-16,804) on platelet aggregation.
Topics: Adenosine Diphosphate; Animals; Dipyridamole; In Vitro Techniques; Male; Methods; Platelet Adhesiveness; Prostaglandins; Rats; Sulfinpyrazone | 1973 |
Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets.
Topics: Adenine Nucleotides; Anti-Inflammatory Agents; Aspirin; Blood Platelets; Carbon Isotopes; Centrifugation; Connective Tissue; Dipyridamole; Drug Synergism; Epinephrine; Flufenamic Acid; Humans; Indomethacin; Mefenamic Acid; Phenylbutazone; Serotonin; Sodium Salicylate; Sulfinpyrazone | 1970 |
[Thrombophilia in early and late sclerosis].
Topics: Age Factors; Anticoagulants; Arteries; Arteriosclerosis; Dipyridamole; Humans; Lipid Metabolism; Nucleosides; Papaverine; Plasminogen; Serine; Sulfinpyrazone; Thromboplastin; Thrombosis | 1968 |
Antiplatelet drugs in the secondary prevention of myocardial infarction. One view of the present position.
Topics: Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Recurrence; Risk; Sulfinpyrazone; Thrombosis | 1980 |
[Inhibitors of thrombocytic function for prophylaxis of coronary heart disease (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anticoagulants; Arteriosclerosis; Aspirin; Coronary Disease; Dipyridamole; Female; Humans; Male; Middle Aged; Platelet Aggregation; Prospective Studies; Sulfinpyrazone | 1982 |
[Infarction prophylaxis--prevention of the sudden heart death? An alternative].
Topics: Adrenergic beta-Antagonists; Anticoagulants; Aspirin; Dipyridamole; Female; Heart Arrest; Humans; Male; Myocardial Infarction; Sulfinpyrazone | 1982 |
Therapeutic interventions in acute myocardial infarction. Survey of the ACCP Section on Clinical Cardiology.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Calcium Channel Blockers; Digitalis Glycosides; Dipyridamole; Drug Utilization; Hospitalization; Humans; Myocardial Infarction; Nitrates; Societies, Medical; Sulfinpyrazone; United States | 1984 |
[Benefits and dangers of preventive thinking in medicine--prevention of thromboembolism].
Topics: Adult; Aspirin; Bandages; Blood Flow Velocity; Coumarins; Dextrans; Dihydroergotamine; Dipyridamole; Hemodilution; Humans; Middle Aged; Myocardial Infarction; Streptokinase; Sulfinpyrazone; Thromboembolism | 1981 |
Treatment of cerebral ischemia.
Topics: Aspirin; Brain Ischemia; Carotid Arteries; Dicumarol; Dipyridamole; Endarterectomy; Heart Murmurs; Heparin; Humans; Hypertension; Ischemic Attack, Transient; Risk; Sulfinpyrazone; Warfarin | 1981 |
Pharmacology of angioplasty and intravascular thrombolysis.
Topics: Angioplasty, Balloon; Anticoagulants; Arteriosclerosis; Aspirin; Blood Platelets; Dextrans; Dipyridamole; Heparin; Humans; Middle Aged; Prostaglandins; Streptokinase; Sulfinpyrazone; Thromboembolism; Urokinase-Type Plasminogen Activator; Warfarin | 1982 |
Antithrombotic treatment.
Topics: Ancrod; Aspirin; Cerebrovascular Disorders; Dextrans; Dipyridamole; Drug Administration Schedule; Heparin; Humans; Myocardial Infarction; Recurrence; Sulfinpyrazone; Thrombosis | 1983 |
Antiplatelet drugs.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Dextrans; Dipyridamole; Epoprostenol; Humans; Sulfinpyrazone; Vascular Diseases | 1983 |
[Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
Topics: Adrenergic beta-Antagonists; Aged; Anticoagulants; Aspirin; Coumarins; Dicumarol; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Platelet Aggregation; Streptokinase; Sulfinpyrazone | 1984 |
Effect of antiplatelet therapy on restenosis after experimental angioplasty.
Topics: Angioplasty, Balloon; Animals; Arteriosclerosis; Aspirin; Blood Platelets; Dipyridamole; Iliac Artery; Rabbits; Radiography; Recurrence; Sulfinpyrazone | 1984 |
The thrombogenicity of Dacron arterial grafts and its modification by platelet inhibitory drugs.
Topics: Arteries; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Dipyridamole; Drug Therapy, Combination; Humans; Microscopy, Electron; Platelet Adhesiveness; Platelet Aggregation; Polyethylene Terephthalates; Sulfinpyrazone; Thiophenes; Thrombosis; Ticlopidine | 1984 |
[Prevention of thrombosis by thrombocyte inhibitors. 1. Cell regulation mechanisms and pharmacological modification].
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Cyclic AMP; Dextrans; Dipyridamole; Humans; Hydroxychloroquine; Indomethacin; Platelet Aggregation; Prostaglandins; Sulfinpyrazone; Thrombosis; Thromboxane A2 | 1980 |
[Divergence between the pharmacologic and clinical effects of inhibitors of prostaglandin synthesis].
Topics: Aspirin; Blood Platelets; Dipyridamole; Drug Interactions; Epoprostenol; Humans; Platelet Aggregation; Prostaglandin Antagonists; Prostaglandin-Endoperoxide Synthases; Salicylates; Salicylic Acid; Sulfinpyrazone; Thrombosis; Thromboxanes | 1984 |
Prostaglandin endoperoxides and thromboxane A2 in thrombus formation in the hamster cheek pouch in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cheek; Cricetinae; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Male; Mesocricetus; Microscopy, Electron; Platelet Aggregation; Sulfinpyrazone; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1984 |
Antithrombotic therapy for vascular prosthesis: an experimental model testing platelet inhibitory drugs.
Topics: Aspirin; Blood Circulation; Blood Platelets; Blood Vessel Prosthesis; Dipyridamole; Humans; Methods; Microscopy, Electron, Scanning; Platelet Adhesiveness; Platelet Aggregation; Polyethylene Terephthalates; Sulfinpyrazone; Thrombosis | 1980 |
Inhibition of thrombocytopenic episodes caused by the Arthus reaction, the sub-lethal Forssman reaction and ADP.
Topics: Adenosine Diphosphate; Animals; Antibodies; Arthus Reaction; Aspirin; Dipyridamole; Forssman Antigen; Guinea Pigs; Humans; Nervous System Diseases; Platelet Count; Pyridines; Sulfides; Sulfinpyrazone; Thiophenes; Thrombocytopenia; Ticlopidine | 1980 |
Ex vivo and in vivo evaluation of drugs that inhibit platelet function.
Topics: Adenosine Diphosphate; Animals; Aspirin; Bleeding Time; Blood Platelets; Collagen; Dipyridamole; Imidazoles; Male; Papio; Platelet Aggregation; Sulfinpyrazone; Thiazines; Thiophenes; Ticlopidine | 1983 |
Drugs in the treatment of thrombo-embolic disease--part I.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Platelets; Carotid Artery Diseases; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Dose-Response Relationship, Drug; Gastrointestinal Hemorrhage; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1983 |
Use of common antiplatelet drugs for vascular diseases.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Artery Bypass; Coronary Disease; Coumarins; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Heart Valves; Humans; Postoperative Care; Sulfinpyrazone | 1983 |
[Platelet antiaggregants in post-myocardial infarct patients: why, which and in what doses?].
Topics: Aspirin; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Recurrence; Sulfinpyrazone | 1983 |
[Cardiovascular lesions induced in rats by vitamin D. Possible protective effect of sulfinpyrazone].
Topics: Animals; Arteries; Cardiovascular Diseases; Dipyridamole; Male; Myocardium; Necrosis; Oxyphenbutazone; Rats; Rats, Inbred Strains; Sulfinpyrazone; Vitamin D | 1983 |
The effects of antithrombotic drugs in patients with left ventricular thrombi: assessment with indium-111 platelet imaging and two-dimensional echocardiography.
Topics: Adult; Aged; Anticoagulants; Aspirin; Dipyridamole; Echocardiography; Heart Ventricles; Humans; Indium; Male; Middle Aged; Platelet Aggregation; Prospective Studies; Radioisotopes; Radionuclide Imaging; Sulfinpyrazone; Thrombosis; Warfarin | 1984 |
[Is modern anti-aggregation therapy effective?].
Topics: Aspirin; Dipyridamole; Fibrinolytic Agents; Humans; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1984 |
Anticoagulants and platelet-active agents in the secondary prevention of coronary artery disease.
Topics: Aged; Anticoagulants; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Epoprostenol; Humans; Middle Aged; Myocardial Infarction; Netherlands; Recurrence; Sulfinpyrazone | 1982 |
Platelet adhesion to collagen in normal and von Willebrand's disease subjects.
Topics: Animals; Aspirin; Blood Platelets; Collagen; Diabetes Mellitus; Dipyridamole; Factor VIII; Humans; Kidney Diseases; Platelet Adhesiveness; Platelet Count; Rats; Sulfinpyrazone; Temperature; von Willebrand Diseases | 1980 |
[Influence of platelet aggregation inhibitors on platelet damage at prosthetic heart valves in-vitro (author's transl)].
Topics: Aspirin; Blood Platelets; Dipyridamole; Heart Valve Prosthesis; Hemolysis; Humans; Lysine; Platelet Aggregation; Propionates; Sulfinpyrazone | 1981 |
Veno-venous allografts: patency, subendothelial proliferation, and the role of platelet-active agents.
Topics: Animals; Aspirin; Blood Platelets; Cell Division; Dipyridamole; Dogs; Female; Graft Survival; Male; Muscle, Smooth, Vascular; Phthalazines; Sulfinpyrazone; Thrombosis; Transplantation, Autologous; Transplantation, Homologous; Veins | 1983 |
Antithrombotic therapy.
Topics: Anticoagulants; Aspirin; Blood Platelets; Dipyridamole; Fibrinolytic Agents; Humans; Sulfinpyrazone; Thrombosis | 1983 |
Dermatomyositis associated with platelet thrombi formation and responsive to antiplatelet therapy.
Topics: Adult; Aspirin; Blood Platelets; Dermatomyositis; Dipyridamole; Female; Humans; Sulfinpyrazone; Thrombosis | 1983 |
The prevention of prosthetic valve thromboembolism. Uses and limitations of anti-platelet drugs.
Topics: Anticoagulants; Aspirin; Bioprosthesis; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Sulfinpyrazone; Thromboembolism | 1983 |
[Conservative therapy of stroke from an internist's viewpoint].
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Digitalis Glycosides; Dipyridamole; Diuretics; Heart Failure; Heme; Humans; Mitral Valve Prolapse; Platelet Aggregation; Sulfinpyrazone; Vasodilator Agents | 1983 |
The inactivation of prostaglandin E2 is decreased by dipyridamole and sulfinpyrazone in isolated rat lungs.
Topics: Animals; Dinoprostone; Dipyridamole; Lung; Male; Perfusion; Prostaglandins E; Rats; Sulfinpyrazone | 1981 |
Non-steroidal anti-inflammatory agents and coronary heart disease.
Topics: Animals; Anti-Inflammatory Agents; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Carotid Artery Diseases; Coronary Disease; Dipyridamole; Female; Fibrin; Humans; Male; Prostaglandins; Sex Factors; Sulfinpyrazone; Thrombosis | 1980 |
[Present situation of therapy with platelet aggregation inhibitors].
Topics: Adult; Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Middle Aged; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Vascular Diseases | 1982 |
Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model.
Topics: Animals; Arteriosclerosis; Cyclosporins; Dipyridamole; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Models, Biological; Peptides, Cyclic; Rats; Sulfinpyrazone; Transplantation, Homologous | 1981 |
Antiplatelet therapy.
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Epoprostenol; Female; Heart Valve Prosthesis; Humans; Male; Platelet Aggregation; Sulfinpyrazone; Thrombophlebitis | 1981 |
Platelets and coronary heart disease: therapy update.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Epoprostenol; Hemostasis; Humans; Propranolol; Prostaglandin Antagonists; Risk; Sulfinpyrazone; Thromboxane A2 | 1982 |
[Prevention of cardiovascular diseases by inhibitors of platelet aggregation (author's transl)].
Topics: Anti-Inflammatory Agents; Aspirin; Cardiovascular Diseases; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1982 |
[Preventive drug therapy of transient cerebral ischemic attacks].
Topics: Anticoagulants; Aspirin; Dipyridamole; Humans; Ischemic Attack, Transient; Platelet Aggregation; Sulfinpyrazone | 1982 |
Inhibitors of immune complex induced human platelet aggregation and release in plasma.
Topics: Antibodies; Antigen-Antibody Complex; Aspirin; Blood Platelets; Depression, Chemical; Dipyridamole; DNA; Humans; Imidazoles; Indomethacin; Lupus Erythematosus, Systemic; Male; Platelet Aggregation; Quinazolines; Receptors, Fc; Sulfinpyrazone | 1982 |
Thrombotic thrombocytopenic purpura.
Topics: Adult; Aspirin; Blood Transfusion; Dipyridamole; Female; Humans; Prednisone; Purpura, Thrombotic Thrombocytopenic; Sulfinpyrazone | 1980 |
[Thrombotic thrombocytopenic purpura: report on 5 cases and current therapy concepts].
Topics: Adult; Aspirin; Dipyridamole; Evaluation Studies as Topic; Exchange Transfusion, Whole Blood; Female; Humans; Male; Prednisone; Pregnancy; Pregnancy Complications, Hematologic; Prognosis; Purpura, Thrombotic Thrombocytopenic; Splenectomy; Sulfinpyrazone | 1981 |
Management of fulminating thrombotic thrombocytopenic purpura.
Topics: Acute Kidney Injury; Colonic Diseases; Colostomy; Dipyridamole; Humans; Male; Middle Aged; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Renal Dialysis; Sulfinpyrazone | 1981 |
Thrombotic thrombocytopenic purpura: prolonged coma with recovery of neurologic function with intensive plasma exchange.
Topics: Aspirin; Coma; Dipyridamole; Female; Humans; Middle Aged; Plasma Exchange; Platelet Count; Prednisolone; Purpura, Thrombotic Thrombocytopenic; Sulfinpyrazone; Vincristine | 1981 |
Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
Topics: Adenosine Diphosphate; Alprostadil; Animals; Aspirin; Dipyridamole; Male; Phosphorylation; Platelet Aggregation; Prostaglandins E; Rats; Rats, Inbred Strains; Sulfinpyrazone; Thiophenes; Ticlopidine | 1982 |
Indium-111 platelet imaging for detection of platelet deposition in abdominal aneurysms and prosthetic arterial grafts.
Topics: Abdomen; Aged; Aneurysm; Aortic Aneurysm; Arteries; Aspirin; Bioprosthesis; Blood Coagulation; Blood Platelets; Dipyridamole; Humans; Indium; Male; Middle Aged; Radioisotopes; Radionuclide Imaging; Sulfinpyrazone | 1981 |
Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acids; Aspirin; Blood Platelets; Collagen; Dipyridamole; Dose-Response Relationship, Drug; Female; Humans; Male; Platelet Aggregation; Sulfinpyrazone; Thromboxane B2; Thromboxanes | 1981 |
[Treatment and prevention of thromboembolism with anti-aggregation drugs].
Topics: Aspirin; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1981 |
Drug interactions with oral anticoagulants.
Topics: Anticoagulants; Benzothiadiazines; Cimetidine; Clofibrate; Dipyridamole; Diuretics; Drug Interactions; Humans; Metronidazole; Sodium Chloride Symporter Inhibitors; Sulfinpyrazone | 1980 |
Antiplatelet drugs after myocardial infarction.
Topics: Aspirin; Dipyridamole; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone | 1980 |
Relationship of plasma anti-heparin activity and platelet survival time in coronary disease.
Topics: Aspirin; Blood Coagulation Factors; Blood Platelets; Cell Survival; Coronary Disease; Dipyridamole; Double-Blind Method; Humans; Indomethacin; Male; Platelet Factor 4; Sulfinpyrazone; Time Factors | 1980 |
Prevention of thrombosis with antiplatelet drugs.
Topics: Aspirin; Blood Platelets; Dipyridamole; Humans; Sulfinpyrazone; Thrombosis | 1980 |
Studies of myocardial infarction.
Topics: Aspirin; Dipyridamole; Drug Combinations; Gastrointestinal Diseases; Humans; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone | 1980 |
[Indications for surgical treatment and medical treatment of atherosclerosis].
Topics: Arteriosclerosis; Aspirin; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Dipyridamole; Humans; Hyperlipidemias; Hypolipidemic Agents; Intracranial Arteriosclerosis; Nicotinic Acids; Sitosterols; Sulfinpyrazone | 1980 |
[Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
Topics: Aspirin; Blood Platelet Disorders; Brain Ischemia; Clofibrate; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1980 |
Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts.
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Internal Mammary-Coronary Artery Anastomosis; Saphenous Vein; Sulfinpyrazone; Ticlopidine | 1998 |
Enhanced platelet aggregability in dogs following myocardial infarction.
Topics: Animals; Blood Platelets; Carrier Proteins; Collagen; Coronary Vessels; Dipyridamole; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Extracellular Matrix Proteins; Glycoproteins; Ligation; Myocardial Infarction; Platelet Aggregation; Quinazolines; Sulfinpyrazone | 1977 |